Smruthi Organics Limited (BOM:540686)

India · Delayed Price · Currency is INR

118.15

-0.15 (-0.13%)

At close: Jun 19, 2026

-1.46% (1Y)

Market Cap	1.35B -8.5%
Revenue (ttm)	1.02B -19.1%
Net Income	34.26M -3.9%
EPS	2.99 -3.9%
Shares Out	11.45M
PE Ratio	39.52
Forward PE	n/a
Dividend	1.50 (1.27%)
Ex-Dividend Date	Jul 31, 2026

Volume	1,790
Open	120.00
Previous Close	118.30
Day's Range	117.25 - 121.40
52-Week Range	95.00 - 164.00
Beta	-0.04
Analysts	Strong Buy
Price Target	73.33 (-37.93%)
Earnings Date	Aug 13, 2026

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1989

Employees 267

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540686

Full Company Profile

Financial Performance

In fiscal year 2026, Smruthi Organics's revenue was 1.02 billion, a decrease of -19.08% compared to the previous year's 1.26 billion. Earnings were 34.26 million, a decrease of -3.85%.

Financial Statements